Skip to main content

Doximity (DOCS) Reports Q3: Everything You Need To Know Ahead Of Earnings

DOCS Cover Image

Medical professional network Doximity (NYSE: DOCS) will be announcing earnings results this Thursday after market close. Here’s what you need to know.

Doximity beat analysts’ revenue expectations by 4.5% last quarter, reporting revenues of $145.9 million, up 15.2% year on year. It was an exceptional quarter for the company, with a solid beat of analysts’ billings estimates and EBITDA guidance for next quarter exceeding analysts’ expectations.

Is Doximity a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Doximity’s revenue to grow 14.8% year on year to $157.1 million, slowing from the 20.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.38 per share.

Doximity Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Doximity has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 4.8% on average.

Looking at Doximity’s peers in the vertical software segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Agilysys delivered year-on-year revenue growth of 16.1%, beating analysts’ expectations by 3.1%, and Cadence Design Systems reported revenues up 10.1%, topping estimates by 0.9%. Agilysys traded up 22.7% following the results while Cadence Design Systems was down 3%.

Read our full analysis of Agilysys’s results here and Cadence Design Systems’s results here.

Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the vertical software stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.2% on average over the last month. Doximity is down 9.5% during the same time and is heading into earnings with an average analyst price target of $71.11 (compared to the current share price of $65.85).

P.S. In tech investing, "Gorillas" are the rare companies that dominate their markets—like Microsoft and Apple did decades ago. Today, the next Gorilla is emerging in AI-powered enterprise software. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.32
+0.00 (0.00%)
AAPL  270.04
+0.00 (0.00%)
AMD  250.05
+0.00 (0.00%)
BAC  53.54
+0.00 (0.00%)
GOOG  278.06
+0.00 (0.00%)
META  627.32
+0.00 (0.00%)
MSFT  514.33
+0.00 (0.00%)
NVDA  198.69
+0.00 (0.00%)
ORCL  248.17
+0.00 (0.00%)
TSLA  444.26
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.